During the first week of May, Sustainable Immunization Financing (SIF) Senior Program Officers Devendra Gnawali and Mariya Savchuk were in Phnom Penh, Cambodia where they met with  counterparts working on immunization financing issues and organized Sabin’s fifth SIF briefing in that country.

Field research, such as that conducted for clinical trials or disease surveillance, is essential to address the many pervasive health issues in developing countries. It relies on extensive collaboration between research institutions and groups on the ground.

In April 2013, an agreement was signed by Sabin and the National Institute of Hygiene and Epidemiology (NIHE), making Vietnam the newest Sustainable Immunization Financing (SIF) Program country.  To kick it off, NIHE and Sabin jointly sponsored a subnational briefing in Da Nang on 13 May.

Taking on 17 diseases with names like schistosomiasis, lymphatic filariasis and dracunculiasis may seem daunting.

So far this year the number of dengue cases in Singapore has already surpassed the number of cases reported in 2012, and it looks like it will just keep rising. As of last week, Singapore was reporting over 6,000 cases, while 2012 saw around 4,600.

Sabin’s Sustainable Immunization Financing Program works with eighteen African and Asian countries to find ways to increase their national immunization program investments.

New York Times reports on price cuts for HPV vaccine

Thanks to Pap tests, fatal cervical cancers are almost unknown today in rich countries. But the disease kills an estimated 275,000 women a year in poor countries where Pap tests are impractical and the vaccine is far too expensive for the average woman to afford, so the price cut could lead to a significant advance in women’s health.

Pages